These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28344605)

  • 41. Improving gynecologic brachytherapy patient experience by optimizing MRI, anesthesia, and scheduling to decrease the length of time tandem and ovoid applicators are in place.
    Usoz M; von Eyben R; Fujimoto DK; Kidd EA
    Brachytherapy; 2020; 19(2):162-167. PubMed ID: 31980387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
    Mikell JK; Klopp AH; Price M; Mourtada F
    Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-resolved in vivo luminescence dosimetry for online error detection in pulsed dose-rate brachytherapy.
    Andersen CE; Nielsen SK; Lindegaard JC; Tanderup K
    Med Phys; 2009 Nov; 36(11):5033-43. PubMed ID: 19994514
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Image Distortions on a Plastic Interstitial Computed Tomography/Magnetic Resonance Brachytherapy Applicator at 3 Tesla Magnetic Resonance Imaging and Their Dosimetric Impact.
    van Heerden LE; van Kesteren Z; Gurney-Champion OJ; Houweling AC; Koedooder K; Rasch CRN; Pieters BR; Bel A
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):710-718. PubMed ID: 29280466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Medanta AOLO template for locally advanced cancer cervix brachytherapy: design and clinical implementation.
    Banerjee S; Kaliyaperumal V; Kataria T; Kamaraj D
    J Contemp Brachytherapy; 2020 Feb; 12(1):44-47. PubMed ID: 32190069
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
    Schindel J; Muruganandham M; Pigge FC; Anderson J; Kim Y
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):387-93. PubMed ID: 23433797
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Direct reconstruction of the Vienna applicator on MR images.
    Berger D; Dimopoulos J; Pötter R; Kirisits C
    Radiother Oncol; 2009 Nov; 93(2):347-51. PubMed ID: 19625096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Verification of needle guidance accuracy in pelvic phantom using registered ultrasound and MRI images for intracavitary/interstitial gynecologic brachytherapy.
    Yang Z; Liu Z; Jiang S; Zeng J; Hu Y; Zhang G
    J Contemp Brachytherapy; 2020 Apr; 12(2):147-159. PubMed ID: 32395139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Automatic tandem and ring reconstruction using MRI for cervical cancer brachytherapy.
    Hrinivich WT; Morcos M; Viswanathan A; Lee J
    Med Phys; 2019 Oct; 46(10):4324-4332. PubMed ID: 31329302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel simple templates for reproducible positioning of skin applicators in brachytherapy.
    Villalba SR; Perez-Calatayud MJ; Bautista JA; Carmona V; Celada F; Tormo A; García-Martinez T; Richart J; Ortega MS; Silla M; Ballester F; Perez-Calatayud J
    J Contemp Brachytherapy; 2016 Aug; 8(4):344-8. PubMed ID: 27648089
    [TBL] [Abstract][Full Text] [Related]  

  • 51. HDR Brachytherapy Dose Distribution is Influenced by the Metal Material of the Applicator.
    Wu CH; Liao YJ; Shiau AC; Lin HY; Hsueh Liu YW; Hsu SM
    Sci Rep; 2015 Dec; 5():17863. PubMed ID: 26658746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 3D image-based adapted high-dose-rate brachytherapy in cervical cancer with and without interstitial needles: measurement of applicator shift between imaging and dose delivery.
    Karlsson L; Thunberg P; With A; Mordhorst LB; Persliden J
    J Contemp Brachytherapy; 2017 Feb; 9(1):52-58. PubMed ID: 28344604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multicentre treatment planning study of MRI-guided brachytherapy for cervical cancer: comparison between tandem-ovoid applicator users.
    Nomden CN; de Leeuw AA; Van Limbergen E; de Brabandere M; Nulens A; Nout RA; Laman M; Ketelaars M; Lutgens L; Reniers B; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):82-7. PubMed ID: 23127774
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outpatient template-guided permanent interstitial brachytherapy using
    Feddock J; Aryal P; Steber C; Edwards J; Cheek D; Randall M
    Brachytherapy; 2017; 16(2):393-401. PubMed ID: 28139423
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
    Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
    Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A 3D-Printable, Low-Cost Obturator for Less Invasive Gynecologic Brachytherapy.
    Rane S; Hanania A; Arango E; Kumar K; Payne L; Dittmar S; Gomber G; Ugarte V; Ludwig M
    Cureus; 2023 Jun; 15(6):e41162. PubMed ID: 37525761
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The use of tetrahedral mesh geometries in Monte Carlo simulation of applicator based brachytherapy dose distributions.
    Fonseca GP; Landry G; White S; D'Amours M; Yoriyaz H; Beaulieu L; Reniers B; Verhaegen F
    Phys Med Biol; 2014 Oct; 59(19):5921-35. PubMed ID: 25210788
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
    Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Daily computed tomography measurement of needle applicator displacement during high-dose-rate interstitial brachytherapy for previously untreated uterine cervical cancer.
    Mikami M; Yoshida K; Takenaka T; Yamazaki H; Kotsuma T; Yoshida M; Aramoto K; Yamada S; Ban C; Tanaka E; Honda K
    Brachytherapy; 2011; 10(4):318-24. PubMed ID: 21236738
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A multicentre 'end to end' dosimetry audit for cervix HDR brachytherapy treatment.
    Palmer AL; Diez P; Gandon L; Wynn-Jones A; Bownes P; Lee C; Aird E; Bidmead M; Lowe G; Bradley D; Nisbet A
    Radiother Oncol; 2015 Feb; 114(2):264-71. PubMed ID: 25583568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.